Three quarters (74%) of GPs have said they experience moral distress because they are unable to prescribe medicines patients need due to ongoing shortages.
This is the finding of a survey carried out by GP indemnity provider MDDUS, which also found almost a third of this group (30%) suffer moral distress every day at work; and 37% several times a week.
Worryingly, nearly half (45%) reported that they have seen patients’ health deteriorate as a result of medicine shortages. Almost nine-in-ten GPs believe the shortage of prescription medicine is severely hampering their ability to practice safely.
More than a third (36%) of respondents said that medicine shortages worsened in 2024, with over four-in-five (83%) saying there was ‘a lack of guidance on how to advise patients about the shortages’, including ‘timescales for when the medicine they need will become available’.
Over nine in 10 GPs (94%) said their workload has increased due to the medicine shortage and more than half (53%) said they were ‘concerned about the risk of a complaint or claim against them or their practice’.
Nearly three quarters (74%) of GPs, reported having to deal with anger or aggression from patients who could not get the first-line medication they want.
One in four (25%) of GPs said they were ‘anxious about coming to work’ because they may be unable to prescribe the medication patients need; and nearly a third (30%) were anxious about having to deal with anger and aggression as a result.
The drugs most affected by shortages, according to the survey, were hormone replacement therapy including oestrogens, progestogens and testosterone (86%), diabetes medicines (GLP-1 RAs such as Ozempic) (80%), epilepsy medicines (42%) and cardiac medicines (30%).
Last week, new analysis revealed that more than three times as many serious shortage protocols (SSPs) were issued in the UK in the two-year period between 2022 and 2024, compared with 2020 to 2022.
One GP said: ‘It is very demoralising working as hard as we can but still being unable to meet patients’ needs due to constraints outside of our control.
‘It makes workdays harder than necessary and mentally exhausting.’
Another GP said: ‘It makes you second guess yourself frequently. Clinical decisions are now being influenced by this lack of medications which leads to increased sense of worry.’
While issues with supply chains were a global problem, Brexit had made the problem harder for the UK to tackle, it found.
MDDUS said it wants governments across the UK to urgently investigate ‘better, more compassionate ways for pressurised medics to seek wellbeing help and speak out about their mental health concerns’.
Dr John Holden, chief medical officer at MDDUS, said: ‘We hear regularly from doctors about the enormous pressures they face every day in the NHS, but the crisis around medicine shortages is making things even worse.
‘It is not uncommon for doctors to contact us when they feel they’re at the very edge of their ability to cope with these pressures.
‘Our survey shows these ongoing shortages are leading to a significant number of GPs questioning whether they want to continue in their role at a time when the NHS needs to retain as many doctors as possible to cope with demand.
‘It is also disturbing to see how many GPs are suffering from professional and personal moral distress because they feel they’re failing their patients by being unable to access the medicine they know is necessary.
‘Regardless of which party forms the government after the general election, the incoming health secretary must urgently prioritise NHS workforce issues – including practitioners’ own mental health and wellbeing – as they get to grips with their new job.’
Community Pharmacy England (CPE)'s latest Pressures Survey, found that medicine supply issues were affecting the majority of community pharmacy teams (72%) ‘multiple times a day’.
Two-thirds (60%) of pharmacy team members surveyed by CPE said GP practices had to be contacted about supply issues on a daily basis.
And eight in 10 pharmacy team members reported that medicine shortages are putting patients’ health at risk.
A version of this article first appeared on our sister title Pulse.
Have your say
Please add your comment in the box below. You can include links, but HTML is not permitted. Please note that comments are not moderated before publication and the views expressed are those of the user and do not reflect the views of The Pharmacist. Remember that submission of comments is governed by our Terms and Conditions. You can also read our full guidelines on article comments here – but please be aware that you are legally liable for any libellous or offensive comments that you make. If you have a complaint about a comment or are concerned that a comment breaches our terms and conditions, please use the ‘Report this comment’ function to alert our web team.